Open AccessDoes Participation in Psychosocial Treatment Augment the Benefit of Clozapine?
Author(s) -
Robert A. Rosenheck,
Janet L. Tekell,
Jeffrey L. Peters,
Joyce A. Cramer,
Alan Fontana,
Weichun Xu,
J. Hywel Thomas,
William Henderson,
Dennis S. Charney
Publication year - 1998
Publication title -
archives of general psychiatry
Language(s) - English
Resource type - Journals
eISSN - 1538-3636
pISSN - 0003-990X
DOI - 10.1001/archpsyc.55.7.618
Subject(s) - psychosocial , clozapine , schizophrenia (object oriented programming) , haloperidol , quality of life (healthcare) , rehabilitation , psychiatry , veterans affairs , medicine , clinical trial , randomized controlled trial , psychology , intervention (counseling) , antipsychotic , clinical psychology , physical therapy , psychotherapist , dopamine
This study examines the role of participation in psychosocial treatment as a mediator of the clinical effectiveness of clozapine.